Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. They know what it takes to succeed in this industry - and have seen what works and what doesn’t and are committed to bringing insight and high quality solutions to clients. In doing so they help them meet the many challenges of today’s complex healthcare marketplace.
The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. Pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.
